Displaying items by tag: epilepsy

UAB will examine cognitive behavior therapy, a form of psychotherapy, that may help reduce the severity of non-epileptic seizures induced by traumatic brain injury.
UAB’s long-running study of cannabidiol reveals potential interactions between CBD and some commonly used anti-epileptic drugs.
A seven-year effort led by a UAB neurologist has established the first guidelines for the use of fMRI in epilepsy surgery.
UAB and Auburn will team up for a study of magnetic resonance imaging techniques that could enhance epilepsy surgery.
Preliminary results from UAB’s CBD oil studies show benefit in seizure control in some patients.
Best of 2015A new surgical robot helps UAB physicians add a new technique for preparing for epilepsy surgery.

Best of 2015 2The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.
A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.
A UAB study sheds new light on the epigenetics of memory formation and memory loss in patients with epilepsy, and the discovery may have implications for many other memory disorders.

Best of 2014 2

The first patient in the Southeast to get the RNS responsive neurostimulation seizure-control device implanted in the brain reports dramatic results at UAB.

UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
UAB’s Epilepsy Center is housed in the Department of Neurology under the direction of Jerzy Szaflarski, M.D., Ph.D.